# Innate Pharma S.A. (IPHA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/ipha for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. The company primarily targets oncology indications across France and internationally, with some programs also addressing inflammatory diseases and viral infections. Its clinical-stage pipeline features several key assets: Lacutamab (IPH4102): An anti-KIR3DL2 antibody undergoing Phase II trials for cutaneous T-cell and peripheral T-cell lymphoma, and also for refractory Sézary syndrome. Monalizum...

## Quote & Key Metrics

As of 2026-10-29:

| Metric | Value |
|---|---|
| Price | $1.50 USD |
| Market Cap | $151.1M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.88 |
| 52-Week Range | $1.17 – $2.71 |
| Dividend Yield (TTM) | — |

## Dividend

IPHA has no dividend payment history in our records.

## Frequently Asked Questions

### What does Innate Pharma S.A. do?

Innate Pharma S.A. (IPHA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is IPHA's market cap?

Innate Pharma S.A. (IPHA) has a market capitalization of approximately $151.1 million, as of October 29, 2026, based on the most recent share price and shares outstanding.

### Does IPHA pay a dividend?

No, Innate Pharma S.A. (IPHA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is IPHA profitable?

Innate Pharma S.A. (IPHA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has IPHA ever paid a dividend?

No. Dividend Data's records show no dividend payments from Innate Pharma S.A. (IPHA). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/ipha
- Dividend history & safety: https://www.dividenddata.com/stocks/ipha/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/ipha/earnings
- Financial statements: https://www.dividenddata.com/stocks/ipha/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/ipha/valuation
- Peer comparison: https://www.dividenddata.com/stocks/ipha/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.